Algernon Pharmaceuticals Inc

Algernon Pharmaceuticals Inc., based in Vancouver, BC, is a clinical-stage Canadian drug development and repurposing company focused on addressing unmet global medical needs through innovative therapeutic applications. The company employs a cost-effective drug repurposing model that leverages existing compounds with known safety profiles to explore new therapeutic uses, significantly reducing the risk of failure and development time. Algernon's product pipeline includes NP251 (Repirinast), originally developed for asthma, and AP188 (NN-Dimethyltryptamine), which is being advanced for potential treatments in stroke and traumatic brain injury. The company is committed to advancing its research programs and establishing new diagnostic and treatment medical clinics, particularly for Alzheimer's disease, utilizing cutting-edge PET scan technology. Generated from the website

Tower One Wireless Corp, founded in 2015 and based in Vancouver, BC, is a public company dedicated to owning and operating high-quality cellular network infrastructure sites primarily in South America and North America. The company focuses on constructing towers in areas with limited or no cellular coverage, facilitating shared usage among multiple operators to mitigate competitive risks. With a Build-to-Suit strategy for Mobile Network Operators, Tower One Wireless ensures long-term site leases are secured before construction begins, generating attractive returns. The company is managed by seasoned industry experts and is currently expanding its 4G LTE and 5G infrastructure across Canada, Colombia, Mexico, Ecuador, and the United States. Generated from the website

Delic Holdings Corp, based in Vancouver, BC, is a leader in the development and accessibility of psychedelic-based treatments, boasting the largest profitable network of clinics in the U.S. The company focuses on long-term solutions that address the root causes of mental health issues, offering effective alternatives to traditional medicines with minimal side effects. Recognizing the growing mental health crisis affecting billions globally, Delic Holdings aims to provide personalized and reliable treatment options that foster emotional wellness. Their integrated approach not only educates the public on psychedelics but also initiates important conversations about mental health management. Generated from the website